menu search

Twist bioscience, eleven therapeutics create synthetic viral rna molecules to develop antiviral vaccines, therapeutics

Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication,...

February 7, 2022, 10:09 am

Twist bioscience, eleven therapeutics create synthetic viral rna molecules to develop antiviral vaccines, therapeutics

Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication,...

February 7, 2022, 10:09 am

Covid-19: pfizer vaccine for kids under 5 ‘really good news,' doctor says

Dr. Payal Patel, infectious diseases physician at the University of Michigan, joins Yahoo Finance's Emi...

February 1, 2022, 5:12 pm

Covid-19: pfizer vaccine for kids under 5 ‘really good news,' doctor says

Dr. Payal Patel, infectious diseases physician at the University of Michigan, joins Yahoo Finance's Emi...

February 1, 2022, 5:12 pm

Covid-19: pfizer vaccine for kids under 5 ‘really good news,' doctor says

Dr. Payal Patel, infectious diseases physician at the University of Michigan, joins Yahoo Finance's Emi...

February 1, 2022, 5:12 pm

Aethlon medical to release third quarter financial results and host conference call on february 14, 2022

SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threat...

January 31, 2022, 8:01 am

Aethlon medical to release third quarter financial results and host conference call on february 14, 2022

SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threat...

January 31, 2022, 8:01 am

Aethlon medical to release third quarter financial results and host conference call on february 14, 2022

SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threat...

January 31, 2022, 8:01 am

Pharmadrug initiates manufacturing of pd-001 for clinical programs in rare cancers and covid-19

PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clini...

January 26, 2022, 9:34 am

Pharmadrug initiates manufacturing of pd-001 for clinical programs in rare cancers and covid-19

PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clini...

January 26, 2022, 9:34 am

Pharmadrug initiates manufacturing of pd-001 for clinical programs in rare cancers and covid-19

PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clini...

January 26, 2022, 9:34 am

Biondvax to present at edison group's open house conference

JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturin...

January 26, 2022, 7:39 am

Biondvax to present at edison group's open house conference

JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturin...

January 26, 2022, 7:39 am

Biondvax to present at edison group's open house conference

JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturin...

January 26, 2022, 7:39 am

Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation

GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a bo...

December 27, 2021, 1:46 pm

Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation

GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a bo...

December 27, 2021, 1:46 pm

Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation

GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a bo...

December 27, 2021, 1:46 pm

Studies claim pfizer vaccine is less effective after a few months, plus cdc booster guidance

Dr. Payal Patel, infectious Diseases Physician, University of Michigan, joins Yahoo Finance's Jared Bli...

October 8, 2021, 3:43 pm

Studies claim pfizer vaccine is less effective after a few months, plus cdc booster guidance

Dr. Payal Patel, infectious Diseases Physician, University of Michigan, joins Yahoo Finance's Jared Bli...

October 8, 2021, 3:43 pm

Studies claim pfizer vaccine is less effective after a few months, plus cdc booster guidance

Dr. Payal Patel, infectious Diseases Physician, University of Michigan, joins Yahoo Finance's Jared Bli...

October 8, 2021, 3:43 pm


Search within

Pages Search Results: